245 results about "Beta-Sitosterol" patented technology

Antiperspirant compositions herein comprise an antiperspirant active, a carrier and a structurant for the carrier which comprises an effective concentration of a combination of at least one sterol and at least one sterol ester, to form a solid or a soft solid. The compositions can be anhydrous and in the form of a suspension of antiperspirant active, or can comprise aqueous emulsions.A particularly suitable sterol comprises beta sitosterol and a particularly preferred sterol ester comprises oryzanol. Preferably the mole ratio of sterol to sterol ester is in the range of 3:1 to 1:2.

Disclosed is a topical preparation for the treatment of topical itch in humans and animals. The said composition consists of Opuntia, Propolis, Stearic Acid, Beeswax, Vegetable Oil and β-sitosterol. Itch includes scratch reaction itch, anal itch, or irritant itch due to plants (e.g., poison ivy), insect bite, sunburn, chemical itch, eczema, pruritis dermatitis, diabetic skin itch, aging skin itch, foot-itch, chickenpox, jock itch, hives, itch of healing burns and wounds, dry winter skin itch, and stress-related scalp itch, etc

The invention discloses a method for measuring sterol in tobaccos. The method comprises the following steps of: (1) deploying sterol standard templates containing internal standard with different concentrations, carrying out GC-MS (Gas Chromatography-Mass Spectrometer) analysis after derivatization, and plotting by utilizing the ratio of the sterol to internal standard peak area and the ratio of the sterol to internal standard concentration to obtain a standard curve; (2) carrying out acid hydrolysis, saponification and direct ultrasonic extraction on samples to be measured, and taking 1 muL for carrying out GC-MS analysis after derivatization; and (3) reading the ratio of the sterol to the internal standard concentration from the standard curve by utilizing the ratio of the sterol to theinternal standard peak area, and then calculating the amount of the sterol. The invention can be used for analyzing cholesterol, ergosterol, campesterol, stigmasterol and beta-sitosterol with a plurality of forms in tobacco leaves at the same time, has the advantages of accurate measurement and simple and convenient operation, and can be widely applied to tobacco industry.

This invention publishes a phytosterol extract from bamboo shoots, its preparation method and application. The phytosterol extract from bamboo shoots mentioned in this invention contains 5~50% sterols, 10~40% of which is beta-sitosterol. The ratio between beta-sitosterol, stigmasterol and campesterol is 10~40:1~3:2~5. The phytosterol extract from bamboo shoots mentioned in this invention performs significant anti-inflammatory and leukemia histiocytosis inhibitory activities and is thus applicable in cosmetics, foods, health products and medicines.

A composition of at least one diacylglycerol and at least one phytosterol and / or phytostanol ester dissolved or dispersed in an edible oil and / or edible fat, and further optionally containing monoglycerides. Phytosterol esters may be beta-sitosterol, campesterol, stigmasterol and brassicasterol esters. Phytostanol esters may be stigmasterol, campestanol and sitostanol. The phytosterol and / or phytostanol esters are preferably esters of C14-C22, preferably C16-C18 saturated or unsaturated fatty acids, particularly oleic, linoleic, linolenic, palmitic and stearic acids. The diacylglycerol(s) are preferably 1,3-di-fatty acyl glycerol(s). A process for preparing compositions enriched with triacylglycerol(s) and phytosterol and / or phytostanol esters of mainly unsaturated fatty acid(s) or of mainly saturated fatty acid(s). Dietary food supplements and alimentary products derived from the above compositions.

The invention provides a preparation method of arctium fruit extract for decreasing blood sugar, wherein the extract comprises Arctiin, Matairesinol, Lappaol A, Lappaol C, Lappaol Fú¼LappaolHú¼Arctignan Eú¼beta-sitosterol and daucosterol.

The invention relates to a repairing emulsion for striae of pregnancy, which belongs to the technical field of daily chemical articles for pregnant and lying-in women. The repairing emulsion is a pure natural plant formula product, and is prepared by blending deionized water, sweet almond oil, hamamelis extract, aloe barbadensis gel, and sunflower seed oil which are taken as main materials and a proper amount of auxiliary material comprising beta-SS according to the mixture ratio, and the sweet almond oil helps to resist the itching and inflammation due to the fact that the sweet almond oil is rich in vitamin B1, vitamin B2, vitamin B6 and VE. The repairing emulsion does not contain soap, sulfate and any essence, can reduce spots on skin, restore the elasticity of the skin, and form a protecting film on the surface of the skin. Specially added beta-sitosterol has functions of promoting the metabolism of the skin and preventing erythema solare and skin aging, and the repairing emulsion is suitable for the pregnant and lying-in women to use.

The invention discloses a method for simultaneously determining stigmasterol, campesterol, beta-sitosterol and squalene in vegetable oil. The method comprises the following steps of: 1) saponifying the vegetable oil, and extracting an unsaponifiable matter in a saponification solution by using an organic solvent; and 2) dissolving the unsaponifiable matter in the organic solvent, and determining by using high-performance liquid chromatography, wherein the high-performance liquid chromatography has the chromatographic conditions that a chromatographic column is a C18 column, a mobile phase is a solvent of which the volume ratio of acetonitrile to water is (90:10) to (100:0), an ultraviolet detection wavelength is 205 to 210 nm, a sample size is 10 to 20 mu L, flow speed is 1.0 to 1.5 mL / min and column temperature is 25 to 30 DEG C. By adoption of the method, effective separation of the campesterol, the stigmasterol, the beta-sitosterol and the squalene in the vegetable oil can be simultaneously realized, consumed time for separation is about 40 min, and components in a chromatogram are eluted in a sequence of the campesterol, the stigmasterol, the beta-sitosterol and the squalene.

The present invention provides a medicine composition with analgesic and anti-inflammatory functions, which belongs to medicine technology field. The medicine composition contains 1-25 parts extract of curcuma, 1-25 parts glucosamine hydrochloride, 1-10 parts beta-sitosterol. The medicine also can add other nutrition compositions such as vitamin C, vitamin E, vitamin K, chondroitin sulfate, vitamin A, vitamin D, immunoglobulin etc. The medicine is processed to various oral agent with acceptable carrier or excipient as substrate in medicine by conventional process. It was verified by animal experiment that the medicine has functions of analgesic and anti-inflammatory, and can be used to prepare medicine and food for preventing chest rib twinging, dysmenorrhea, shoulder and arm pain, injuries from impacts, gout, rheumatoid arthritis etc.

The invention provides a method for extracting pinostrobin and beta-sitosterol from exocarp of kiskatom, which belongs to the technical field of pinostrobin and beta-sitosterol extracting methods. The method comprises the following steps: washing and crushing the expocarp of the kiskatom; and then diacolating and extracting the expocarp after the expocarp is swelled by ethanol, and concentrating the collected diacolation solution to prepare a concentrated solution; extracting the concentrated solution by an organic solvent to prepare extract dry powder; and separating the extract dry powder by silica gel column chromatography with the following steps: a) carrying out gradient elution on the extract dry powder by sherwood oil and a sherwood oil-ethyl acetate mixed solution with volume ratio of between 45:1 and 15:1 respectively, and combining two kinds of eluate; and b) carrying out the gradient elution on the combined eluate by the sherwood oil-ethyl acetate mixed solution with volume ratio of between 10:1 and 1:20, and concentrating and crystallizing the combined eluate in the reduced pressure to prepare pinostrobin coarse crystal and beta-sitosterol coarse crystal; and carrying out recrystallization treatment to prepare pinostrobin crystal and beta-sitosterol crystal. The method has the advantages of simple process and low manufacturing cost, and the contents of the prepared pinostrobin crystal and the beta-sitosterol crystal are more than 98 percent.

The invention relates to a method for extracting luteolin and beta-sitosterol from peanut shells. The method comprises the following steps: taking the peanut shells as materials, cleaning the peanut shells to remove impurities, crushing the cleaned peanut shells, performing extraction on the crushed peanut shells by an ethanol solution, carrying out filtration, decolorization and concentration under reduced pressure to obtain a luteolin and beta-sitosterol mixture, then mixing the luteolin and beta-sitosterol mixture with an alkali liquor, after that, carrying out extraction separation to obtain beta-sitosterol, performing extraction after pH adjustment to obtain a luteolin crude product, and performing alcohol dissolution, crystallization and recrystallization on the crude product to obtain a luteolin product with relatively high purity. The method is simple to operate, demands less on equipment, lowers the manufacturing cost of luteolin and reduces the risk of environmental pollution.

The composition of the invention relates generally to a nutritional supplement, which is capable of ameliorating the biologically detrimental effects of dihydrotestosterone (DHT). The present composition comprises a combination of natural plant-derived extracts, and minerals including Saw palmetto berry extract; pumpkin seed (Curcubito pepo) extract; beta-sitosterol; quercetin; Polygonum multiflorum root extract; a lycopene, for example from tomato extract; isoflavones, for example from Pueraria lobata root extract, and soybeans; zinc; selenium or any combination thereof. The ingredients are combined into any suitable form to be administered, and consumed by an individual for the prevention or treatment of hair loss, or prostatic hyperplasia or both.

The invention relates to the technical fields of grease and grease refining processing, in particular to health-care corn oil and a preparation process thereof. The corn oil disclosed by the invention is subjected to the processes of hydration deguming, deacidification, decoloration, deodorization, dewaxing, filtration, filling, finished products acquisition, and the like. When the deodorization is finished, the corn oil is charged with nitrogen at low temperature, and the product quality and the demand on product stability in the processes of production and storage are guaranteed; the deodorization oil temperature of the corn oil provided by the invention is lower than the deodorization oil temperature of common corn oil so that the content of beta-sitosterol and vitamin E is obviously higher than that of common corn oil; and the health-care corn oil has the functions of assisting to reduce blood fat and strengthen immunity.

A novel use is disclosed of liposomes that contain phytosterol (e.g., β-sitosterol, campesterol, stigmasterol, brassicasterol, ergosterol, and ergostadienol, and so forth). It has been newly discovered that liposomes that contain phytosterol have a cancer metastasis inhibiting activity. Cancer metastasis is inhibited by the oral administration of liposomes that contain phytosterol and these liposomes are therefore useful for the prevention and treatment of cancer.

The invention provides a breast enlarging cream, and relates to the field of cosmetics. The formula of the cream comprises the following components: a raw materials of a group A, raw materials of a group B, raw materials of a group C, and raw materials of a group D; the raw materials of the group A comprise hydrogenated lecithin, cholesteryl stearate, cetearyl alcohol, poly(dimethylsiloxane), cyclomethicone, glyceryl tri(2-ethylhexanoate), tocopherol, beta-sitosterol, shea butter, and methylparaben; the raw materials of the group B comprise water, a humectant, sodium hyaluronate, and butylene glycol; the raw materials of the group C comprise polyacrylamide, and C13-14 isoparaffin; and the raw materials of the group D comprise diglycerin, an extract product of pueraria roots, an extract product of Cassia fistula, an extract product of Cydonia oblonga, protein fermentation products of chlorella / Lupinus albus, an extract product of India Indian myrrh resin, hydrolyzed collagen and an antiseptic. The breast enlarging cream has the advantages of reasonable formula, usage convenience, and safety and environmental protection of raw materials; the cream can add brilliance and elasticity of breasts, and enlarge breast at the same time.

The invention provides a nigre resource obtained by the alkali refining of rice bran crude oil. The preparation technology comprises the following steps of: by taking diethyl ether as an extract solvent, washing nigre by diethyl ether of which the weight is 3-10 times as heavy as the weight of the nigre, separating fatty acid from phytosterol-containing rice bran oil, freezing the rice bran oil, crystallizing, separating out phytosterol crude product and rice bran oil, dissolving the phytosterol curde product by 94%-97% of ethanol, and decoloring by adding activated carbon to obtain phytosterol finished product finally. The phytosterol extracted from the rice bran crude oil is all natural, free from toxicity and side effects, less in damage to phytosterol products, good in beta-sitosterol retaining property, high in content which can be more than 40%, low in solvent loss, higher in yield, better in safety, and is more suitable for the addition agent and the like for pharmacy (antilipemic agent), food and cosmetics.

The present invention relates to a composition for increasing testosterone physiological levels comprising: a) a sufficient amount of at least one aromatase inhibitor chosen from a flavone substituted with at least one methoxy group at position 3′,4′,5 or 7, any combinations thereof, and any di, tri or tetra combinations thereof; and a flavanone substituted with at least one methoxy group at position 3′,4′,5 or 7, any combinations thereof, and any di, tri or tetra combinations thereof; and b) a sufficient amount of at least one 5α-reductase inhibitor that inhibit testosterone conversion to DHT, such as beta-sitosterols; in association with a pharmaceutically acceptable carrier.

The invention discloses a preparation method of ginkgo leaf lipoid components having antibacterial activities. Ginkgo leaf which is a raw material is extracted with a non-polar solvent, and undergoes molecular distillation separation, column chromatography, re-crystallization and purification to obtain eight compounds (sequentially comprising isophytol, nerolidol, linalool, beta-sitosterol acetate, beta-sitosterol, stigmasterol, ergosterol and daucosterol), polypentenol, ginkgo leaf lipoid total unsaponifiable matters, ginkgo leaf lipoid crystals, a ginkgo leaf lipoid light fraction and a ginkgo leaf lipoid heavy friction. The eight compounds, polypentenol, the ginkgo leaf lipoid total unsaponifiable matters, the ginkgo leaf lipoid crystals, the ginkgo leaf lipoid light fraction and the ginkgo leaf lipoid heavy friction have inhibition effects on salmonellas, Staphylococcus aureus and Aspergillus niger.

The invention relates to a skin spray based on deep repair and long-lasting moisture preservation. The skin spray is prepared from antarctic ice brown alga extract, auroral alga extract, arctic draparnaldia extract, jellyfish extract, sea spring water, hydrolyzed lupin protein, fragrant citrus fruit extract, 1,3-propanediol, poly-gamma-sodium glutamate, beta-sitosterol sodium sulfate, tocopheryl linoleate, wild soybean seed extract and other raw materials. Compared with the prior art, the skin spray has the advantages that the varieties and use quantities of the raw materials are strictly regulated, so that the technical formula of replenishing water to the surface layer (cuticle), replenishing nutrients (lipopolysaccharide, protein, microelements and the like) to the deep layer and activating cells meets the skin moisture preservation mechanism better, and the optimized formula design of the ingredients with the moisture preservation barrier and repair synergism is achieved.

The invention provides a new use of beta-sitosterol in preparation of a medicine for treating or preventing influenza A, and further provides the medicine for treating or preventing the influenza A. The medicine comprises an active component of the beta-sitosterol. The inventor of the application finds that the beta-sitosterol has a significant inhibitory activity for an inflammatory reaction mediated by influenza A virus. The fluorescence real-time quantitative polymerase chain reaction (PCR) is used for confirming that the beta-sitosterol can obviously inhibit abnormal expressions of A549 inflammatory cytokines infected by an H1N1 virus and show a dose-dependent relationship; the Western blotting is adopted to confirm that the beta-sitosterol can inhibit activation with host inflammation related signaling pathways and show the dose-dependent relationship. Animal experiments show that the beta-sitosterol can significantly inhibit lung injuries and inflammations induced by influenza virus A (H1N1).

The invention discloses a sterol derivative of beta-sitosterol, beta-stigmasterol and cholesterol, and is shown as a formula VI. The invention also discloses a preparation method of the sterol derivative. The invention also discloses application of the sterol derivative to the aspect of preparation of wound healing promoting medicine. By starting from easily obtained natural products, the beta-sitosterol, the beta-stigmasterol and the cholesterol are used as starting raw materials; the synthetic method is simple; better operability and reaction yield are realized. The prepared sterol derivative has the obvious wound healing promoting activity; the multiplication, migration and collagen synthesis capability on L929 mechanocytes is obviously higher than that of the raw material and positive control medicine recombinant human bFGF (basic fibroblast growth factor). Compared with protide type medicine (such as bFGF), the prepared sterol derivative has more diversified dosage forms and medication modes; the reference is provided for the application in the field of wound healing promoting. The formula VI is shown as the accompanying diagram.

Compositions and methods for urea silicone gels for treating hyperkeratotic skin diseases that may benefit from barrier protection and from urea silicone gel's ability to return water balance to the skin are disclosed. Skin conditions that may be treated with urea silicone gels may be excessive dryness, callus, corns, old and new scars, and keloids, among others. Disclosed urea silicone gels may include micronized urea USP, and an anhydrous silicone base, among other ingredients. Anhydrous silicone base may include Amazonian oils such as pracaxi oil and seje oil, which are rich in oleic, linolenic, linoleic acids, and sterols, particularly beta-sitosterol and stigmasterol, which may increase skin permeability to urea. Additionally, because of the high content of unsaturated fatty acids of pracaxi oil and seje oil, disclosed urea silicone gel may exhibit an enhanced hydrating effect on skin cells, over-moisturizing and hydrating tough, thick hyperkeratotic conditions.

The invention provides saussurea involucrata cell squalene synthase (SiSQS) gene as well as products coded by same and application thereof. The complementary deoxyribonucleic acid (cDNA) length of the SiSQS gene is 1846bp. A SiSQS recombinant expression vector is obtained by connecting the SiSQS gene and a prokaryotic expression vector, and SiSQS is prepared by the SiSQS recombinant expression vector; the SiSQS can be applied to squalene preparation taking farnesyl pyrophosphate as substrate. The SiSQS gene provided by the invention can be used for increasing the content of chemical component beta-sitosterol of saussurea involucrata cells by a genetic engineering technology, and is especially applied to the culture field of saussurea involucrata and cells and / or tissues of plants which belong to the species similar to the saussurea involucrata.

The invention discloses a health care tea prepared by using narrow leaves and tender branches of wood of shinyleaf yellowhorn, and discloses a preparation process of the health care tea. The preparation process specifically comprises the steps of acquiring tea leaves, sorting, withering, beating, carrying out stir fixation, rolling, drying, sterilizing, screening, and the like. The health care tea contains beneficial ingredients such as chrysophanol, emodin monomethyl ether, beta-sitosterol, frangulic acid, 2,5-dimethoxy benzoquinone, quercetin, general flavone, and sugar as well as polysaccharide and glucoside, tannin, coumarin, protein, polypeptide and amino acid, strontium, zinc, barium, iron copper, manganese and other microelements.

The invention relates to full filbert peptide nourishment containing filbert active peptides. The full filbert peptide nourishment contains 3-90% by weight of mixed active peptides of oligopeptide, short chain polypeptide and polypeptide and also contains linoleic acid, oleic acid, linolenic acid, phospholipid, flavonoid substances, carotene, VB1, VB2, VB12, VC, VC, VA, niacin, calcium, phosphorus, iron, potassium, magnesium, beta-sitosterol, glucose and water. The full filbert peptide nourishment is prepared by the following steps of: adding water into filbert or filbert pulp for pulping; pumping the pulp into a colloid mill to be ground, wherein the fineness of the colloid mill is 210-250 meshes; then homogenizing the powder through an ultrahigh homogenizer until the fineness of the material reaches 700-800 meshes; then performing pulse type steam impact at a high temperature and a high pressure; adding lipase after reducing the temperature to stand at a constant temperature for biochemical treatment; adjusting the PH value to 6-8; then adding neutral protease to stand at a constant temperature for biochemical treatment again; and finally, separating out a full filbert peptide original liquid so as to prepare the full filbert peptide nourishment.

The invention provides a number of substances, which increases the curative effect of anti-cancer Indole-3-methanol (I3C) and derivatives, including reduction selenium, vitamin B6, Beta-sitosterol, vitamin D, vitamin E, resveratrol and other substances. The reduction selenium or the medicine combination of reduction selenium and one or a plurality of other substances, or the medicine compound of the substances and Indole-3-methanol and derivatives can obviously increase the anti-cancer effect of the Indole-3-methanol and derivatives. With curative or auxiliary curative effect, the invention in particular can effectively cure prostatic hyperplasia and prostate cancer, thus reducing the dosage of Indole-3-methanol and derivatives.

The invention discloses a method of extracting beta-sitosterol from n-pentanol solvent crystallization. Under certain temperature, alcohol of 95 percent with 7 times the amount of crude sterols is used to carry out thermal dissolution on the crude sterols; impurities are filtered through micropores; filter liquor is pumped into a cold separation reactor be filtered after being cooled to 10 DEG C; a filter cake and the alcohol are added into a reactor according to the mass ratio of 3 : 1, fully mixed and filtered; n-pentanol and the filter cake with the mass ratio of 3 to 5 : 1 are added into the reactor, temperature then rises to 40 DEGC plus / minus 2 DEG C, and the n-pentanol and the filter cake are fully mixed keeping the temperature unchanged; the steps are repeated to ensure that content of the beta-sitosterol in the filter cake achieves above 90 percent, and then the filter cake is dried in vacuum, crashed, sieved and packaged into a finished product. Compared with other solvent methods, the invention has high product yield and low cost. Solvent mixture is used in other solvent methods, while the invention uses single solvent n-pentanol having easy recovery and simple operation.

The invention discloses breast enlargement and beauty cream which comprises the following ingredients in percentage by weight: 15-20 percent of an emollient, 3-5 percent of an emulsifier, 5-20 percent of a moisturizer, 0.5-1 percent of a nutrient, 40-60 percent of functional active components, 0.2-0.5 percent of preservative and antioxidants, and 40-50 percent of a filler. The emollient comprises stearic acid, cetearyl alcohol, glyceryl stearate and shea butter. The emulsifier comprises PPG-1trideceth-6, PEG-100glyceryl stearate and pentaerythrityl tetraisostearate. The moisturizer comprises 6 percent butanediol, glycerin and trimethyl glycine. The nutrient comprises sodium hyaluronate HA, beta-sitosterol, tocopherol and oil soluble azone. The functional active components comprise the following ingredients in mass percent: 5-10 percent of semen sinapis extracting solution, 5-10 of percent soy isoflavones extracting solution, 8-15 percent of leonurus artemisia extracting solution, 8-15 percent of kudzuvine root extracting solution and 10-15 percent of humulus lupulus extracting solution. The filler is water. The breast enlargement and beauty cream has the functions of breast enlargement and health care, and can maintain the health and shape of breasts in an all-dimensional, safe and effective manner.

The invention relates to diaper cream for babies, which belongs to the technical field of daily chemical articles for the babies. The diaper cream for the babies is a pure natural plant formula product, takes castor oil and sunflower seed oil as main materials, uses an auxiliary material comprising beta-sitosterol, utilizes the barrier action of the castor oil to stop the harmful weather from hurting skin, and has the effect of moistening the skin; the sunflower seed oil taken as a best softening agent can provide a protecting film for the skin; and the specially added beta-sitosterol has good permeability to the skin, can retain the moisture of the surface of the skin, promote the metabolism of the skin, and inhibit the inflammation of the skin. A unique formula of the diaper cream for the babies has better effects on aspects such as the permeability, the water retention property, the inhibition of skin inflammation, is suitable for the babies to use, and is favorable for the healthy growth of the babies.

The invention discloses a beta-sitosterol type catechinic acid liposolubility antioxidant and a preparation method thereof. The preparation method comprises the steps that butanedioic anhydride and beta-sitosterol react; under the action of a coupling reagent, intermediate products react with catechinic acid with hydroxyl on benzene rings being protected till the reaction is completed; and obtained products are subjected to deprotection, and the beta-sitosterol type catechinic acid liposolubility antioxidant is obtained through posttreatment. The beta-sitosterol type catechinic has a very good liposolubility antioxidant function. The beta-sitosterol type catechinic has a very good antioxygenic property in grease. The beta-sitosterol type catechinic is low in price and suitable for industrialized production and application. Meanwhile, the preparation method for the beta-sitosterol type catechinic is simple in process, simple, practical and suitable for industrialized mass production.